Trial Profile
Impact on the Estimated Prohormone Convertase Enzyme Activity (PC1/3 and 2) in Japanese Type 2 Diabetes Treated with Sitagliptin
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2014
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Mar 2014 New trial record